Clinical Trial Update: Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial comparing AQUAVAN Injection to DISOPRIVAN Injectable Emulsion for anesthesia during coronary artery bypass surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• AQUAVAN Injection (propofol)
• DISOPRIVAN Injectable Emulsion (propofol)

Snippet

Sponsor: Eisai Inc. | Conditions: Ischemic Coronary Artery Disease, Coronary Artery Bypass Surgery | Phase 2 | Status: COMPLETED